SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (519)12/19/1997 3:10:00 PM
From: Wesley0428  Read Replies (2) of 849
 
This could be of interest to Matritech, who knows

<<<Intelligent Medical Imaging Establishes National Reference Sites and Begins OEM Discussions

PALM BEACH GARDENS, Fla.--(BW HealthWire)--Dec. 15, 1997--

...Intelligent Medical Imaging, Inc. (Nasdaq:IMII) the developer and
marketer of the MICRO21(tm) system, an intelligent, automated
microscope system for diagnostic use in hospitals, commercial
reference and physician group practice laboratories...

...Mr. Fitzmorris added, "The OEM market represents a significant
market potential for the MICRO21. In the past two months, Abbott,
Bayer and Coulter, have initiated OEM related discussion with us,
ranging from integrating the MICRO21 with their new generation
hematology analyzers, to using the IMI automated slide maker
integrated with one of the hematology analyzers, to joint development
of some very exciting microscopic procedures on the MICRO21...

CONTACT:

AT THE COMPANY

Tyce M. Fitzmorris Gene Cochran

Chairman, CEO & Chief Financial Officer

President 561/627-0344

561/627-0344>>>

Hmmm Bayer... joint development of exciting new procedures...

Could be.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext